Humana Inc. (HUM)
NYSE: HUMHealthcareHealthcare PlansUSD
At close: Oct 7, 3:59 PM ET · Delayed 15 min
After hours: 396.51 +0.08%
HUM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $47.58B
- P/E (TTM)
- 37.45
- Forward P/E
- 23.88
- EPS (TTM)
- $10.58
- Dividend yield
- 0.89% ($3.54)
- Ex-dividend date
- Jun 26, 2026
- 52-week range
- 163.11 – 428.88
- Day range
- 394.81 – 410.00
- Volume / Avg
- 1.69M / 1.23M
- Beta
- —
- Shares outstanding
- 120.08M
- Next earnings
- Nov 6, 2026
52-week range
HUM stock today
On Oct 7, HUM ended the session at $396.21, shedding $8.06 (1.99%), versus the S&P 500's 0.22% decline. At this level, HUM sits near the top of its 52-week range of $163.11 to $428.88: 7.6% below the high, set on Jul 16, 2026 and 142.9% above the low. HUM is up 58.9% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 37.9%.
At 37.4x trailing earnings, Humana trades above the peer-group median of 25.5x. Its forward P/E of 23.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Humana's next earnings report is expected on Nov 6, 2026. Humana pays an annual dividend of $3.54 per share, a 0.89% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Humana
Company profileHumana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- CEO
- Mr. James A. Rechtin M.B.A.
- Headquarters
- Louisville, KY
- Employees
- 67,060
- Website
- humana.com
Financial highlights
Full financialsIn fiscal 2025, Humana generated $129.66 billion in revenue, up 10.1% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $1.19 billion (-1.6% year over year), for a net margin of 0.9% versus a median of 3.0% in the prior 5 years. Operating margin was 2.1%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| Growth | +10.11% | +10.70% | +14.54% | +11.81% | +7.66% |
| Net income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| EPS (diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
Analyst forecast
ForecastConsensus (26 analysts)
buy
Avg. price target
$423.74+6.95%
- Strong buy 2
- Buy 11
- Hold 12
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 6, 2026
- EPS estimate
- $-1.04
- Last reported (Q1 2026)
- Apr 29, 2026
- EPS actual vs est.
- $9.83 vs —
Dividends
Dividend history- Annual dividend
- $3.54
- Dividend yield
- 0.89%
- Last payment
- $0.885
- Ex-dividend date
- Jun 26, 2026
HUM news
All HUM news- UnitedHealth Q3 Coming Up: Two Questions Investors Can't IgnoreNasdaqUNH, HUM, ELV
- Noteworthy Wednesday Option Activity: MMM, HUM, WMTNasdaqMMM, HUM, WMT
- UnitedHealth Reshapes Florida WellMed Operations With TPG DealNasdaqUNH, HUM, ELV
- UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?NasdaqUNH, HUM, ELV
- Is UnitedHealth Finally Turning the Corner After a Tough 2025?NasdaqUNH, HUM, ELV
- CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing.NasdaqCVS, UNH, HUM, MFG
Humana peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CNCCentene Corporation | 65.00 | +0.61% | $32.11B | vs HUM |
| CIThe Cigna Group | 278.47 | +1.49% | $73.58B | vs HUM |
| MOHMolina Healthcare Inc | 194.84 | -0.17% | $10.17B | vs HUM |
| OSCROscar Health Inc. Class A | 32.91 | +1.76% | $10.16B | vs HUM |
| ELVElevance Health Inc. | 404.32 | +1.06% | $87.68B | vs HUM |
| CLOVClover Health Investments Corp. Class A | 4.56 | -0.87% | $2.42B | vs HUM |
| PGNYProgyny Inc. | 27.55 | +6.33% | $2.11B | vs HUM |
| ALHCAlignment Healthcare Inc. | 8.55 | +2.15% | $1.77B | vs HUM |
Indexes, lists and sector
Index membership
Appears in lists
Humana stock FAQ
What is Humana's stock price today?
HUM last traded at $396.21 as of Oct 7, 3:59 PM EDT, down 1.99% on the day. Prices are delayed at least 15 minutes.
Does Humana pay a dividend?
Yes. Humana pays $3.54 per share annually, a 0.89% yield. The most recent dividend of $0.885 had an ex-dividend date of Jun 26, 2026.
When is Humana's next earnings date?
Humana is expected to report earnings on Friday, November 6, 2026. Analysts expect EPS of $-1.04.
What is HUM's P/E ratio?
HUM trades at a trailing P/E ratio of 37.45 and a forward P/E of 23.88, compared with a median of 25.5 for its closest peers.
Is Humana in the S&P 500?
Yes. Humana (HUM) is a constituent of the S&P 500 index.
Who is Humana's CEO?
Mr. James A. Rechtin M.B.A. is the chief executive officer of Humana Inc., which has about 67,060 employees.
Has HUM ever split its stock?
Yes. The most recent HUM stock split was a 3-for-2 split on Aug 1, 1991, one of 4 splits on record.